FindTrial
Sign In

Canceled by the investigator. The effect of COVID-19 on cognitive function of people with Alzheimer's disease and its influencing factors

The effect of COVID-19 on cognitive function of people with Alzheimer's disease and its influencing factors - The impact of COVID-19 on Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069292
Enrollment
Unknown
Registered
2023-03-13
Start date
2023-03-13
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Case group:N/A

Sponsors

Beijing Geriatric Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=65 years; 2. NINCDS-ADRDA diagnosis is likely to be AD; 3. Within 3 months of recovery from COVID-19 infection; 4. Complete cognitive tests (MMSE, etc.) within 3 months prior to COVID-19 infection.

Exclusion criteria

Exclusion criteria: 1. Severe hearing impairment; 2. Severe language disorder; 3. Severe functional failure of important organs and critically ill patients; 4. Unable or unwilling to cooperate for any other reason.

Design outcomes

Primary

MeasureTime frame
Mini-Mental State Examination, MMSE;—

Secondary

MeasureTime frame
Alzheimer's Disease Rating Scale - Cognitive component;1 minute animal naming;Neuropsychological Inventory;Geriatric Depression Scale;Activities of Daily Living;—

Countries

China

Contacts

Public ContactLyu Jihui

Beijing Geriatric Hospital

lvjihui@139.com+86 10 6240 2842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026